$27.04 +0.32 (%) Medicines Co - NASDAQ

Dec. 18, 2014 | 04:00 PM

Partner Headlines

  1. The Medicines Company Surges Amid Credit Suisse Upgrade

    Benzinga | Nov. 20, 2014 | 10:16AM EST
  2. US Stock Futures Surge Ahead Of Earnings, ADP Data

    Benzinga | Nov. 5, 2014 | 07:18AM EST
  3. The Medicines Company Announces First Patient Enrollment In Phase 3 Studies Of CARBAVANCE in Development For The Treatment Of Serious Bacterial Infections Due To Gram-Negative Bacteria

    Benzinga | Nov. 5, 2014 | 06:36AM EST
  4. Midday Gainers From October 28: Buffalo Wild Wings, Integrated Device Technology, Cliffs Natural Resources And More

    Benzinga | Oct. 28, 2014 | 13:22PM EST
  5. Morning Market Movers

    Benzinga | Oct. 28, 2014 | 09:48AM EST
  6. Bank Of America Q3 Small & Mid-Cap Biotech Preview

    Benzinga | Oct. 20, 2014 | 16:58PM EST
  7. BACTIVTM Phase 3 SOLO II Trial Results Published In The Journal Clinical Infectious Diseases

    Benzinga | Oct. 9, 2014 | 16:53PM EST
  8. Actavis Expands Antibiotics Presence With Durata Buy

    IBD | Oct. 6, 2014 | 10:58AM EST
  9. Conferences/Events Scheduled for Week of Jun. 9th to Jun. 13th

    Benzinga | Jun. 10, 2014 | 11:04AM EST
  10. Benzinga's Top Downgrades

    Benzinga | Apr. 17, 2014 | 08:02AM EST
  11. Benzinga's Top Downgrades

    Benzinga | Apr. 2, 2014 | 08:03AM EST
  12. Medicines Co.

    IBD | Apr. 1, 2014 | 18:53PM EST
  13. Mid-Afternoon Market Update: Compuware Holds Onto Gains, Clearwire Remains Down

    Benzinga | Apr. 1, 2014 | 16:00PM EST
  14. Stocks Higher In Afternoon; Thor Industires Jumps

    IBD | Apr. 1, 2014 | 13:40PM EST
  15. Mid-Day Market Update: Verint Shares Jump On Upbeat Results; Medicines Co. Falls

    Benzinga | Apr. 1, 2014 | 12:39PM EST
  16. Medicines Co. Down On Setback In Hospira Patent Case

    IBD | Apr. 1, 2014 | 12:12PM EST
  17. Stocks Hitting 52-Week Lows

    Benzinga | Apr. 1, 2014 | 10:30AM EST
  18. Mid-Morning Market Update: Markets Gain; Ford March Sales Rise 3%

    Benzinga | Apr. 1, 2014 | 10:28AM EST
  19. Morning Market Losers

    Benzinga | Apr. 1, 2014 | 09:53AM EST
  20. Benzinga's Top #PreMarket Losers

    Benzinga | Apr. 1, 2014 | 08:21AM EST
  21. Medicines Co. earnings miss

    IBD | Feb. 19, 2014 | 18:54PM EST
  22. Earnings Scheduled For February 19, 2014

    Benzinga | Feb. 19, 2014 | 04:30AM EST
  23. FDA nixes Medicines' drug

    IBD | Feb. 13, 2014 | 18:33PM EST
  24. Mid-Afternoon Market Update: Market Rally Levels Out As Time Warner/Comcast Deal Holds The Spotlight

    Benzinga | Feb. 13, 2014 | 15:48PM EST
  25. Mid-Day Market Update: U.S. Stocks Rise; Orbitz Shares Surge On Upbeat Results

    Benzinga | Feb. 13, 2014 | 12:44PM EST
  26. Medicines Co. Downgraded After FDA Panel Rejects Drug

    IBD | Feb. 13, 2014 | 12:38PM EST
  27. Mid-Morning Market Update: Markets Drop; Comcast To Acquire Time Warner Cable For $45.2B

    Benzinga | Feb. 13, 2014 | 10:25AM EST
  28. Stocks Hitting 52-Week Lows

    Benzinga | Feb. 13, 2014 | 10:14AM EST
  29. UPDATE: Credit Suisse Downgrades The Medicines Company Following Negative Cangrelor Panel

    Benzinga | Feb. 13, 2014 | 08:38AM EST
  30. Benzinga's Top #PreMarket Losers

    Benzinga | Feb. 13, 2014 | 08:18AM EST
  31. UPDATE: The Medicines Co. Reminds Investors of FDA CRDAC Meeting Today, Says Proposing Cangrelor Be Indicated to Maintain P2Y12 Inhibition

    Benzinga | Feb. 12, 2014 | 07:07AM EST
  32. Mid-Afternoon Market Update: Red Robin Continues to Rally as The Medicines Company Drops

    Benzinga | Feb. 10, 2014 | 16:16PM EST
  33. Leaders Hold Near Buy Points Despite Monday Sell-Off

    IBD | Jan. 14, 2014 | 16:31PM EST
  34. Biotech Stocks Back On Top, Led By Biogen, Alexion

    IBD | Jan. 13, 2014 | 18:07PM EST
  35. Scanning Leading Stocks For Earnings Growth In 2014

    IBD | Dec. 18, 2013 | 18:00PM EST
  36. Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Lowest PEG Ratio

    Benzinga | Dec. 10, 2013 | 04:08AM EST
  37. Medicines acquires Rempex

    IBD | Dec. 4, 2013 | 18:36PM EST
  38. Benzinga's M&A Chatter for Wednesday December 4, 2013

    Benzinga | Dec. 4, 2013 | 17:21PM EST
  39. Medicines Co. Acquires Rempex Pharma; Street Applauds

    IBD | Dec. 4, 2013 | 11:21AM EST
  40. US Stock Futures Edge Higher Ahead Of ADP Report

    Benzinga | Dec. 4, 2013 | 07:12AM EST
  41. Five Medical Stocks Leaders Trade Near New Highs

    IBD | Nov. 22, 2013 | 18:49PM EST
  42. A Few Stocks Form Bases, But Have Flaws

    IBD | Nov. 20, 2013 | 18:30PM EST
  43. Strong Pipeline Expected To Drive Growth At Medicines Co.

    IBD | Nov. 15, 2013 | 18:30PM EST
  44. Medicines Co. Mostly Steady After Low-Volume Breakout

    IBD | Nov. 12, 2013 | 17:37PM EST
  45. ViroPharma Gets Bought Out; Medicines Clears Entry

    IBD | Nov. 11, 2013 | 17:13PM EST
  46. Santarus Earnings Should Top 4 Hot Small-Cap Medicals

    IBD | Nov. 7, 2013 | 08:02AM EST
  47. Top 4 NASDAQ Stocks In The Drug Manufacturers-Other Industry With The Highest EPS Estimates

    Benzinga | Nov. 7, 2013 | 04:19AM EST
  48. LinkedIn, Alliance Fiber Lead Q3 Young Gun Earnings

    IBD | Oct. 30, 2013 | 08:02AM EST
  49. Medicines Co. In Late Stages Of Base Formation

    IBD | Oct. 25, 2013 | 16:38PM EST
  50. Medicines Co. sales topped

    IBD | Oct. 23, 2013 | 18:47PM EST
Trading Center